IFP Advisors’s bluebird bio BLUE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-7
Closed -$3 4845
2025
Q2
$3 Buy
+7
New +$31 ﹤0.01% 4893
2025
Q1
Sell
-10,750
Closed -$96.3K 4348
2024
Q4
$96.3K Buy
10,750
+10,225
+1,948% +$89.4K ﹤0.01% 1482
2024
Q3
$5.46K Buy
525
+275
+110% +$4.57K ﹤0.01% 2636
2024
Q2
$4.92K Buy
+250
New +$5.01K ﹤0.01% 2563
2022
Q4
Sell
-27
Closed -$100K 4619
2022
Q3
$100K Hold
27
﹤0.01% 1854
2022
Q2
$100K Hold
27
﹤0.01% 1685
2022
Q1
$100K Buy
+27
New +$3.56K ﹤0.01% 1685
2021
Q1
Sell
-78
Closed -$38.4K 3015
2020
Q4
$46K Sell
78
-1
-1% -$634 ﹤0.01% 1476
2020
Q3
$57K Buy
79
+1
+1% +$780 ﹤0.01% 1238
2020
Q2
$61K Buy
78
+1
+1% +$754 ﹤0.01% 1128
2020
Q1
$45K Buy
77
+21
+38% +$20.5K ﹤0.01% 1166
2019
Q4
$64K Sell
56
-2
-3% -$2.17K ﹤0.01% 1155
2019
Q3
$72K Buy
+58
New +$88.6K ﹤0.01% 1201
2019
Q1
$2K Sell
1
-98
-99% -$173K ﹤0.01% 2065
2018
Q4
$125K Sell
99
-44
-31% -$67.5K 0.01% 1082
2018
Q3
$270K Sell
143
-22
-13% -$45.4K 0.01% 921
2018
Q2
$336K Buy
165
+24
+17% +$54.7K 0.01% 833
2018
Q1
$326K Hold
141
0.01% 789
2017
Q4
$326K Buy
141
+85
+152% +$173K 0.01% 789
2017
Q3
$100K Sell
56
-163
-74% -$228K ﹤0.01% 1554
2017
Q2
$298K Buy
219
+207
+1,725% +$250K 0.01% 902
2017
Q1
$14K Sell
12
-3
-20% -$3.06K ﹤0.01% 2706
2016
Q4
$12K Buy
15
+7
+88% +$5.56K ﹤0.01% 2780
2016
Q3
$7K Buy
8
+4
+100% +$2.9K ﹤0.01% 3033
2016
Q2
$2K Buy
4
+3
+300% +$1.7K ﹤0.01% 3442
2016
Q1
$2K Sell
1
-9
-90% -$5.53K ﹤0.01% 2065
2015
Q4
$8K Buy
+10
New +$9.99K ﹤0.01% 2680

IFP Advisors's BLUE Position: Q3 2025 in Review

IFP Advisors sold out of bluebird bio (BLUE) in Q3 2025, closing a stake of 7 shares — an estimated $3 sold.

IFP Advisors first reported a position in BLUE in Q4 2015 and held it in 27 quarters. The position peaked at $336K in Q2 2018. 0 funds tracked by Wall St. Rank hold BLUE as of Q3 2025.

  • IFP Advisors reported no remaining bluebird bio position as of Q3 2025 after selling out during the quarter.
  • IFP Advisors sold 7 bluebird bio shares in Q3 2025, an estimated $3.
  • IFP Advisors first reported a position in bluebird bio in Q4 2015 and held it in 27 quarters.
  • IFP Advisors's bluebird bio position peaked at $336K in Q2 2018.
  • 0 funds tracked by Wall St. Rank held bluebird bio as of Q3 2025.

Based on IFP Advisors's 13F filing for Q3 2025, filed 2 Dec 2025.